The virus that causes COVID-19 can persist in aerosol form, some studies suggest. But the potential for transmission depends on many factors, including infectiousness, dose and ventilation...
Large crowds, tear gas and jail cells could contribute to transmission of the virus. But it would not be easy to separate that danger from the risks of states reopening businesses and workplaces...
Researchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good news
Amyloid, the leading target for dementia therapy, faces skepticism after drug failures
A new device could ultimately increase the number of usable livers for transplants and could perhaps preserve other types of organs
LabCorp’s Pixel kits rely on self-swabbing and mailing samples, and they have yet to be scaled up for widespread use
Glucose metabolism plays a key role in the cytokine storm seen in influenza, and the link could have potential implications for novel coronavirus infections
Numerous contenders—from a controversial malaria medication to treatments that regulate the immune system—are now in clinical trials
Johns Hopkins health security expert Tom Inglesby discusses the need for widespread testing, protective equipment and face coverings
By adjusting for population, researchers have identified rural areas in several states that could be disproportionally affected by COVID-19
The drug remdesivir is effective against many other viruses, and some experts are optimistic that it—or similar compounds—may work for the pathogen responsible for COVID-19
Health security expert Caitlin Rivers talks about what schools, businesses and individuals can do to minimize the impact
Whenever there’s a new outbreak, scientists rush to calculate a number called R0, or R-naught
Whenever there’s a new outbreak, scientists rush to calculate a number called R 0 , or R-naught. Why? It’s been a critical part of the scientific effort to understand just how transmissible the new virus is...
The country has shut down all travel to and from Wuhan and nearby cities in an attempt to curb the spread of a new virus
Federal disease agency director Anthony Fauci discusses the novel pathogen that has, so far, sickened hundreds in Asia and one person in the U.S.
Dozens of compounds approved for other purposes can kill cancer cells selectively
The first research center of its kind in the country is bringing renewed rigor to the investigation of the drugs’ therapeutic uses
The pathogen has been newly identified in eight cases of encephalitis in Germany over the past 20 years
Scientists engineered the bacterium to produce psilocybin
